Home
NewsNewsKindbody and Future Family partner to expand access to fertility care through flexible financing and personalised clinical support. Offering up to $50,000 in funding, concierge guidance, and inclusive services, the collaboration helps reduce financial barriers, enabling more individuals and families to pursue IVF and other reproductive treatments with confidence.
Kindbody, a leading fertility and family-building benefits provider and clinical care delivery platform, has announced a landmark partnership with Future Family, the premier financing platform designed exclusively for fertility patients. This collaboration is specifically designed to Expand Access to Fertility Care by providing patients with flexible, patient-centred financing options integrated with dedicated clinical and financial support.
The partnership addresses a significant challenge in the reproductive health sector: the high cost of treatment. With the average IVF cycle costing between $15,000 and $20,000 and many patients requiring multiple cycles, financial barriers often prevent individuals from pursuing their dreams of parenthood. By joining forces, Kindbody and Future Family aim to alleviate this burden through comprehensive financial solutions and expert guidance.
“Access to affordable, compassionate fertility care has been our mission since day one,” said Brian Miller, Chief Operating Officer at Kindbody. “Partnering with Future Family allows us to remove one of the most significant barriers our patients face—the cost of treatment. Together, we're ensuring that financial constraints don't stand between people and their dreams of building a family.”
Through this initiative to Expand Access to Fertility Care, Kindbody patients can now access personalised financing of up to $50,000 with competitive rates and flexible terms tailored to individual treatment plans. The platform offers a soft pre-qualification process that does not impact credit scores, allowing patients to explore their options with peace of mind.
Beyond the financial aspect, the partnership provides a "concierge" approach to care. Patients are paired with dedicated Financial Specialists to customise payment plans and RN Care Coaches who provide expert clinical guidance throughout the journey. The coverage is inclusive, encompassing IVF, IUI, egg freezing, medications, genetic testing, and donor services.
Claire Tomkins, Founder of Future Family, founded the platform based on her own struggles with the high out-of-pocket costs of IVF. She noted, “Future Family was born from personal experience—I built my own family through IVF and experienced first hand the high out of pocket cost of IVF. Financial stress can compound an already emotional journey. We've helped more than 10,000 patients move forward with care, and partnering with Kindbody allows us to extend that support to even more families seeking compassionate, accessible fertility treatment.”
This collaboration reflects a shared commitment to making family building more equitable. The services are designed to Expand Access to Fertility Care for a diverse range of patients, including LGBTQ+ individuals, single parents by choice, and anyone facing fertility challenges. Future Family's financing features, such as no prepayment penalties and interest that accrues only on funds used, ensure that the process is as transparent and manageable as possible.
Kindbody continues its mission to democratise women’s health and reproductive care through its national network of signature clinics and virtual care options. Together with Future Family’s specialised financing, they are removing the financial barriers that stand in the way of building the families of the future. Patients can begin the process by applying for financing online to explore options specific to their unique treatment timelines.
Technology-Enabled Cryostorage is transforming fertility storage as Reprotech and TMRW combine expertise in digital specimen management and biorepository services. The partnership enhances scalability, safety, and efficiency while supporting clinics with advanced solutions. This strategic move positions the combined company to lead innovation and meet growing global demand in cryostorage services.
First AI-powered egg-freezing program has been initiated by Sunfish with an intent to get rid of uncertainty within the fertility preservation space, offering personalised insights and higher success predictability for women.
3billion has gone on to launch the Family Insight Test using WES and WGS analysis aimed at targeting couples who cannot get pregnant for no apparent reason, helping them discover hidden genetic factors affecting fertility.
Arbor Fertility™ with 8 locations in Missouri & Illinois has designed a streamlined patient-centred approach leading to Affordable, Accessible Fertility Care, making high-quality treatment available without financial burden.
BGI Genomics, a Chinese biotechnology company is working on AI-Powered Chromosome Screening Tools so as to accelerate and enhance IVF treatments in China, aiming to reduce genetic abnormalities and increase live birth outcomes.
Before taking a call on IVF, survey conducted in the U.S., UK, Ireland, and Canada suggests that people are looking for complete & less expensive options to treat root causes of infertility.
The Tennessee State Law could change how the embryos are handled at the time of treatment, thereby making the IVF clinic services in the state more expensive for patients seeking fertility care.
